November 1, 2017 /

FibroGen Update on Pamrevlumab & Enrolling Non-Ambulatory Study (October 2017)

Parent Project Muscular Dystrophy by: Parent Project Muscular Dystrophy

FibroGen Update on Pamrevlumab & Enrolling Non-Ambulatory Study (October 2017)

PPMD and FibroGen hosted a webinar on October 25, 2017 to hear a community update on FibroGen’s development of Pamrevlumab and currently enrolling FGCL-3019-079 non-ambulatory study in Duchenne.

Research & Clinical Trial Webinars,
Webinars

Join Our Mailing List

This field is for validation purposes and should be left unchanged.
BBB Accredited Charity logoCharity Navigator Four Star Charity logoNational Health Council Standards of Excellence Certification Program logo